Waters Corporation Prices $3.5 Billion Senior Notes Offering
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy WAT?
Source: PRnewswire
- Offering Size: Waters Corporation announced a $3.5 billion senior notes offering through its subsidiary Augusta SpinCo Corporation, expected to close on March 23, 2026, demonstrating the company's robust financing capability in the capital markets.
- Debt Repayment Strategy: The net proceeds from this offering will be used to repay $3.5 billion of delayed draw term loan incurred by Augusta in February 2026, aimed at optimizing the company's capital structure and reducing financial costs.
- Underwriter Lineup: Barclays Capital Inc. serves as the global coordinator, while Citigroup, J.P. Morgan, BofA Securities, and HSBC act as active bookrunners, indicating strong market interest and confidence in the offering.
- Compliance and Transparency: The offering is made under an effective shelf registration statement in accordance with U.S. securities law, ensuring investors receive necessary investment information, thereby enhancing the company's credibility and transparency in the capital markets.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy WAT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on WAT
Wall Street analysts forecast WAT stock price to rise
13 Analyst Rating
8 Buy
5 Hold
0 Sell
Moderate Buy
Current: 290.020
Low
350.00
Averages
414.08
High
480.00
Current: 290.020
Low
350.00
Averages
414.08
High
480.00
About WAT
Waters Corporation offers analytical instruments, separations technologies, and software, serving the life, materials, food, and environmental sciences. The Company's segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments. It operates directly in over 35 countries and has products available in more than 100 countries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Waters Corporation Prices $3.5 Billion Senior Notes Offering
- Offering Size: Waters Corporation announced a $3.5 billion senior notes offering through its subsidiary Augusta SpinCo Corporation, which includes $650 million of 4.321% notes, $600 million of 4.398% notes, $750 million of 4.656% notes, $750 million of 4.945% notes, and $750 million of 5.245% notes, all issued at 100% of their principal amount, reflecting strong confidence in the capital markets.
- Use of Proceeds: The net proceeds from this offering will be used alongside cash on hand to repay $3.5 billion of delayed draw term loan incurred by Augusta in February 2026, significantly improving the company's financial structure and reducing debt burden, thereby enhancing future financial flexibility.
- Underwriter Lineup: The offering is being coordinated globally by Barclays Capital Inc., with Citigroup, J.P. Morgan, BofA Securities, and HSBC participating as active bookrunners, indicating strong market recognition and support for the transaction.
- Compliance and Transparency: The offering is made under an effective shelf registration statement in accordance with U.S. securities laws, ensuring transparency and compliance, which further boosts investor confidence and lays a solid foundation for the company's future financing activities.
See More
Waters Corp. Prices $3.5 Billion Senior Notes Offering
- Offering Size: Waters Corp. successfully priced a $3.5 billion multi-tranche senior notes offering through its subsidiary Augusta SpinCo Corp., featuring five tranches maturing between 2027 and 2036, with coupon rates ranging from 4.321% to 5.245%, all issued at par, indicating strong market acceptance of its debt instruments.
- Debt Repayment Strategy: The net proceeds from this offering will be used alongside cash on hand to repay a $3.5 billion delayed draw term loan incurred in February, aimed at optimizing the capital structure and reducing financial costs, thereby enhancing the company's financial flexibility.
- Market Reaction: In pre-market trading on the New York Stock Exchange, Waters Corp.'s stock rose by 0.15% to $297.41, reflecting investor confidence in the company's debt management and future financial health.
- Closing Timeline: The offering is expected to close on March 23, marking a proactive financing strategy in the capital markets that further supports the company's long-term growth objectives.
See More
Waters Corporation Prices $3.5 Billion Senior Notes Offering
- Offering Size: Waters Corporation announced a $3.5 billion senior notes offering through its subsidiary Augusta SpinCo Corporation, expected to close on March 23, 2026, demonstrating the company's robust financing capability in the capital markets.
- Debt Repayment Strategy: The net proceeds from this offering will be used to repay $3.5 billion of delayed draw term loan incurred by Augusta in February 2026, aimed at optimizing the company's capital structure and reducing financial costs.
- Underwriter Lineup: Barclays Capital Inc. serves as the global coordinator, while Citigroup, J.P. Morgan, BofA Securities, and HSBC act as active bookrunners, indicating strong market interest and confidence in the offering.
- Compliance and Transparency: The offering is made under an effective shelf registration statement in accordance with U.S. securities law, ensuring investors receive necessary investment information, thereby enhancing the company's credibility and transparency in the capital markets.
See More
Insider Buying by Waters and Arvinas Directors
- Waters Insider Purchase: Waters' Director Richard H. Fearon bought 1,000 shares at $306.34 each for a total of $306,340, marking his first purchase in the past year, indicating confidence in the company's future.
- Market Opportunity: Waters shares traded as low as $295.02 on Wednesday, 3.7% below Fearon's purchase price, presenting a relatively low entry point for investors, despite the stock being down about 1.2% on the day.
- Arvinas Insider Purchase: Arvinas' Director Briggs Morrison purchased 20,000 shares at $13.40 each for a total investment of $268,070, reflecting his positive outlook on the company's prospects.
- Historical Purchase Comparison: Prior to this purchase, Morrison had bought 227,010 shares at $7.57 each in the past year, demonstrating his sustained confidence in Arvinas, even as the stock fell approximately 3.2% on Wednesday.
See More
Waters CEO to Participate in Healthcare Conference
- Conference Participation: Waters Corporation's CEO, Dr. Udit Batra, will participate in the TD Cowen Healthcare Conference on March 2, 2026, at 11:10 AM ET, highlighting the company's leadership in life sciences.
- Live Webcast: The event will be streamed live on the 'Events & Presentations' section of Waters' Investor Relations website, ensuring global investors can access real-time updates and enhancing corporate transparency.
- Replay Availability: A replay of the webcast will be available for 90 days post-event, allowing investors who missed the live session to catch up, thereby improving information accessibility and engagement.
- Company Background: Waters Corporation focuses on life sciences and diagnostics, dedicated to accelerating scientific innovation through analytical technologies and informatics, driving the release of high-quality medicines and early disease detection, showcasing its global market influence.
See More
Becton Dickinson Lowers Fiscal 2026 Earnings Guidance Amid Sales Beat
- Sales Performance Beat: Becton Dickinson reported sales of $5.25 billion, slightly exceeding the consensus of $5.15 billion, indicating stable performance in a challenging economic environment despite ongoing headwinds.
- Earnings Guidance Cut: The company lowered its fiscal 2026 adjusted earnings guidance from $14.75-$15.05 per share to $12.35-$12.65, below the consensus of $14.72, reflecting pressures and uncertainties in future business operations.
- Analyst Rating Changes: RBC Capital Markets reduced its price target for Becton Dickinson from $210 to $172, citing FY26 as a transition year with an expected organic revenue growth of 2.5%, which may impact investor confidence moving forward.
- Market Reaction: Following the announcement, Becton Dickinson's shares fell by 17.44% to $171.23, indicating investor concerns regarding the company's growth potential, especially in light of multiple business headwinds.
See More
Waters Corporation Prices $3.5 Billion Senior Notes Offering
- Offering Size: Waters Corporation announced a $3.5 billion senior notes offering through its subsidiary Augusta SpinCo Corporation, which includes $650 million of 4.321% notes, $600 million of 4.398% notes, $750 million of 4.656% notes, $750 million of 4.945% notes, and $750 million of 5.245% notes, all issued at 100% of their principal amount, reflecting strong confidence in the capital markets.
- Use of Proceeds: The net proceeds from this offering will be used alongside cash on hand to repay $3.5 billion of delayed draw term loan incurred by Augusta in February 2026, significantly improving the company's financial structure and reducing debt burden, thereby enhancing future financial flexibility.
- Underwriter Lineup: The offering is being coordinated globally by Barclays Capital Inc., with Citigroup, J.P. Morgan, BofA Securities, and HSBC participating as active bookrunners, indicating strong market recognition and support for the transaction.
- Compliance and Transparency: The offering is made under an effective shelf registration statement in accordance with U.S. securities laws, ensuring transparency and compliance, which further boosts investor confidence and lays a solid foundation for the company's future financing activities.
See More
Waters Corp. Prices $3.5 Billion Senior Notes Offering
- Offering Size: Waters Corp. successfully priced a $3.5 billion multi-tranche senior notes offering through its subsidiary Augusta SpinCo Corp., featuring five tranches maturing between 2027 and 2036, with coupon rates ranging from 4.321% to 5.245%, all issued at par, indicating strong market acceptance of its debt instruments.
- Debt Repayment Strategy: The net proceeds from this offering will be used alongside cash on hand to repay a $3.5 billion delayed draw term loan incurred in February, aimed at optimizing the capital structure and reducing financial costs, thereby enhancing the company's financial flexibility.
- Market Reaction: In pre-market trading on the New York Stock Exchange, Waters Corp.'s stock rose by 0.15% to $297.41, reflecting investor confidence in the company's debt management and future financial health.
- Closing Timeline: The offering is expected to close on March 23, marking a proactive financing strategy in the capital markets that further supports the company's long-term growth objectives.
See More
Waters Corporation Prices $3.5 Billion Senior Notes Offering
- Offering Size: Waters Corporation announced a $3.5 billion senior notes offering through its subsidiary Augusta SpinCo Corporation, expected to close on March 23, 2026, demonstrating the company's robust financing capability in the capital markets.
- Debt Repayment Strategy: The net proceeds from this offering will be used to repay $3.5 billion of delayed draw term loan incurred by Augusta in February 2026, aimed at optimizing the company's capital structure and reducing financial costs.
- Underwriter Lineup: Barclays Capital Inc. serves as the global coordinator, while Citigroup, J.P. Morgan, BofA Securities, and HSBC act as active bookrunners, indicating strong market interest and confidence in the offering.
- Compliance and Transparency: The offering is made under an effective shelf registration statement in accordance with U.S. securities law, ensuring investors receive necessary investment information, thereby enhancing the company's credibility and transparency in the capital markets.
See More
Insider Buying by Waters and Arvinas Directors
- Waters Insider Purchase: Waters' Director Richard H. Fearon bought 1,000 shares at $306.34 each for a total of $306,340, marking his first purchase in the past year, indicating confidence in the company's future.
- Market Opportunity: Waters shares traded as low as $295.02 on Wednesday, 3.7% below Fearon's purchase price, presenting a relatively low entry point for investors, despite the stock being down about 1.2% on the day.
- Arvinas Insider Purchase: Arvinas' Director Briggs Morrison purchased 20,000 shares at $13.40 each for a total investment of $268,070, reflecting his positive outlook on the company's prospects.
- Historical Purchase Comparison: Prior to this purchase, Morrison had bought 227,010 shares at $7.57 each in the past year, demonstrating his sustained confidence in Arvinas, even as the stock fell approximately 3.2% on Wednesday.
See More
Waters CEO to Participate in Healthcare Conference
- Conference Participation: Waters Corporation's CEO, Dr. Udit Batra, will participate in the TD Cowen Healthcare Conference on March 2, 2026, at 11:10 AM ET, highlighting the company's leadership in life sciences.
- Live Webcast: The event will be streamed live on the 'Events & Presentations' section of Waters' Investor Relations website, ensuring global investors can access real-time updates and enhancing corporate transparency.
- Replay Availability: A replay of the webcast will be available for 90 days post-event, allowing investors who missed the live session to catch up, thereby improving information accessibility and engagement.
- Company Background: Waters Corporation focuses on life sciences and diagnostics, dedicated to accelerating scientific innovation through analytical technologies and informatics, driving the release of high-quality medicines and early disease detection, showcasing its global market influence.
See More
Becton Dickinson Lowers Fiscal 2026 Earnings Guidance Amid Sales Beat
- Sales Performance Beat: Becton Dickinson reported sales of $5.25 billion, slightly exceeding the consensus of $5.15 billion, indicating stable performance in a challenging economic environment despite ongoing headwinds.
- Earnings Guidance Cut: The company lowered its fiscal 2026 adjusted earnings guidance from $14.75-$15.05 per share to $12.35-$12.65, below the consensus of $14.72, reflecting pressures and uncertainties in future business operations.
- Analyst Rating Changes: RBC Capital Markets reduced its price target for Becton Dickinson from $210 to $172, citing FY26 as a transition year with an expected organic revenue growth of 2.5%, which may impact investor confidence moving forward.
- Market Reaction: Following the announcement, Becton Dickinson's shares fell by 17.44% to $171.23, indicating investor concerns regarding the company's growth potential, especially in light of multiple business headwinds.
See More
